154 related articles for article (PubMed ID: 37180100)
1. VIGET: A web portal for study of vaccine-induced host responses based on Reactome pathways and ImmPort data.
Brunson T; Sanati N; Huffman A; Masci AM; Zheng J; Cooke MF; Conley P; He Y; Wu G
Front Immunol; 2023; 14():1141030. PubMed ID: 37180100
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.
Koren MA; Lin L; Eckels KH; De La Barrera R; Dussupt V; Donofrio G; Sondergaard EL; Mills KT; Robb ML; Lee C; Adedeji O; Keiser PB; Curley JM; Copeland NK; Crowell TA; Hutter JN; Hamer MJ; Valencia-Ruiz A; Darden J; Peel S; Amare MF; Mebrahtu T; Costanzo M; Krebs SJ; Gromowski GD; Jarman RG; Thomas SJ; Michael NL; Modjarrad K
Lancet Infect Dis; 2023 Oct; 23(10):1175-1185. PubMed ID: 37390836
[TBL] [Abstract][Full Text] [Related]
3. VaximmutorDB: A Web-Based Vaccine Immune Factor Database and Its Application for Understanding Vaccine-Induced Immune Mechanisms.
Berke K; Sun P; Ong E; Sanati N; Huffman A; Brunson T; Loney F; Ostrow J; Racz R; Zhao B; Xiang Z; Masci AM; Zheng J; Wu G; He Y
Front Immunol; 2021; 12():639491. PubMed ID: 33777032
[TBL] [Abstract][Full Text] [Related]
4. Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?
Michel R; Berger F; Ravelonarivo J; Dussart P; Dia M; Nacher M; Rogier S; Moua D; Sarr FD; Diop OM; Sall AA; Baril L
Vaccine; 2015 May; 33(20):2301-6. PubMed ID: 25843268
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
[TBL] [Abstract][Full Text] [Related]
6. Illuminate the Functions of Dark Proteins Using the Reactome-IDG Web Portal.
Beavers D; Brunson T; Sanati N; Matthews L; Haw R; Shorser S; Sevilla C; Viteri G; Conley P; Rothfels K; Hermjakob H; Stein L; D'Eustachio P; Wu G
Curr Protoc; 2023 Jul; 3(7):e845. PubMed ID: 37467006
[TBL] [Abstract][Full Text] [Related]
7. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
[TBL] [Abstract][Full Text] [Related]
8. Measurement of Cellular Immune Response to Viral Infection and Vaccination.
Bouwman W; Verhaegh W; Holtzer L; van de Stolpe A
Front Immunol; 2020; 11():575074. PubMed ID: 33193365
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
Juan-Giner A; Kimathi D; Grantz KH; Hamaluba M; Kazooba P; Njuguna P; Fall G; Dia M; Bob NS; Monath TP; Barrett AD; Hombach J; Mulogo EM; Ampeire I; Karanja HK; Nyehangane D; Mwanga-Amumpaire J; Cummings DAT; Bejon P; Warimwe GM; Grais RF
Lancet; 2021 Jan; 397(10269):119-127. PubMed ID: 33422245
[TBL] [Abstract][Full Text] [Related]
10. Vaccination by scarification with 17D yellow fever vaccine prepared at Yaba, Lagos, Nigeria.
CANNON DA; DEWHURST F
Ann Trop Med Parasitol; 1953 Dec; 47(4):381-93. PubMed ID: 13125271
[No Abstract] [Full Text] [Related]
11. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.
Nascimento Silva JR; Camacho LA; Siqueira MM; Freire Mde S; Castro YP; Maia Mde L; Yamamura AM; Martins RM; Leal Mde L;
Vaccine; 2011 Aug; 29(37):6327-34. PubMed ID: 21640779
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.
Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK
J Travel Med; 2015; 22(1):48-56. PubMed ID: 25308927
[TBL] [Abstract][Full Text] [Related]
13. An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures.
Pereira RC; Silva AN; Souza MC; Silva MV; Neves PP; Silva AA; Matos DD; Herrera MA; Yamamura AM; Freire MS; Gaspar LP; Caride E
Vaccine; 2015 Aug; 33(35):4261-8. PubMed ID: 25862300
[TBL] [Abstract][Full Text] [Related]
14. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
Jong EC; Kaplan KM; Eves KA; Taddeo CA; Lakkis HD; Kuter BJ
J Travel Med; 2002; 9(2):66-70. PubMed ID: 12044272
[TBL] [Abstract][Full Text] [Related]
15. Yellow fever virus vaccination: an emblematic model to elucidate robust human immune responses.
Bovay A; Fuertes Marraco SA; Speiser DE
Hum Vaccin Immunother; 2021 Aug; 17(8):2471-2481. PubMed ID: 33909542
[TBL] [Abstract][Full Text] [Related]
16. WHO position on the use of fractional doses - June 2017, addendum to vaccines and vaccination against yellow fever WHO: Position paper - June 2013.
World Health Organization
Vaccine; 2017 Oct; 35(43):5751-5752. PubMed ID: 28689653
[TBL] [Abstract][Full Text] [Related]
17. POLICI: A web application for visualising and extracting yellow fever vaccination coverage in Africa.
Hamlet A; Jean K; Yactayo S; Benzler J; Cibrelus L; Ferguson N; Garske T
Vaccine; 2019 Mar; 37(11):1384-1388. PubMed ID: 30770224
[TBL] [Abstract][Full Text] [Related]
18. Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model.
Julander JG; Trent DW; Monath TP
Vaccine; 2011 Aug; 29(35):6008-16. PubMed ID: 21718741
[TBL] [Abstract][Full Text] [Related]
19. The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences.
Ferreira CC; Campi-Azevedo AC; Peruhype-Magalhāes V; Costa-Pereira C; Albuquerque CP; Muniz LF; Yokoy de Souza T; Oliveira ACV; Martins-Filho OA; da Mota LMH
Expert Rev Vaccines; 2018 Jan; 17(1):79-90. PubMed ID: 29172832
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial.
Sandberg JT; Löfling M; Varnaitė R; Emgård J; Al-Tawil N; Lindquist L; Gredmark-Russ S; Klingström J; Loré K; Blom K; Ljunggren HG
PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010616. PubMed ID: 36758067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
